Joost Kluiver
dr.
I have a central role in all research projects focusing on the role of noncoding RNAs. My main aim is to understanding how small and long non-coding RNAs contribute to the pathogenesis of B-cell lymphoma. Ongoing studies include MYC-regulated miRNAs and lncRNAs, as well as miRNA-lncRNA interactions and the role of circular RNAs. We apply state-of-the-art methodology including AGO2-RIP, RNA-FISH and gain- and loss-of-function screens using shRNA and CRISPR-Cas technology.
Latest publications
(87)
Activities
(27)
Press/Media
(1)
Prizes
(1)
Datasets
(3)
Supervised work
(11)
Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition
Published in: PLoS ONE
Access to document
10.1371/journal.pone.0029275
document
MicroRNA (miRNA) sponges are transcripts with repeated miRNA antisense sequences that can sequester miRNAs from endogenous targets. MiRNA sponges are valuable tools for miRNA loss-of-function studies both in vitro and in vivo. We developed a fast and flexible method to generate miRNA sponges and tested their efficiency in various assays. Using a single directional ligation reaction we generated sponges with 10 or more miRNA binding sites. Luciferase and AGO2-immuno precipitation (IP) assays confirmed effective binding of the miRNAs to the sponges. Using a GFP competition assay we showed...
Joost Kluiver, Johan H. Gibcus, Chris Hettinga, Annelies Adema, Mareike K. S. Richter, Nancy Halsema, Izabella Slezak-Prochazka, Ye Ding, Bart-Jan Kroesen, Anke van den Berg
MiR-17/106b seed family regulates p21 in Hodgkin’s lymphoma
Published in: The Journal of Pathology
Access to document
10.1002/path.2958
Hodgkin’s lymphoma (HL) is a B cell-derived lymphoma characterized by a minority of malignant Hodgkin Reed-Sternberg (HRS) cells that have lost their normal B cell phenotype. Alterations in the cell cycle and apoptosis pathways might contribute to their resistance to apoptosis and sustained cell cycle progression. A key player in both cell cycle arrest and apoptosis is CDKN1A, encoding p21(waf/cip1) (p21). P21 is regulated by p53 and can function as a cell cycle inhibitor when in the nucleus or as an apoptosis inhibitor when localized in the cytoplasm....
Johan H. Gibcus, Bart-Jan Kroesen, Roelof Koster, Nancy Halsema, Debora de Jong, Steven de Jong, Sibrand Poppema, Joost Kluiver, Arjan Diepstra, Anke van den Berg
THE ROLE OF MIRNAS IN HODGKIN LYMPHOMA
A. van den Berg, Ping L. Tan, J. Gibcus, J. Kluiver, Slezack-Prochzka, N. Halsema, D. de Jong, B-J Kroesen, S. Poppema
MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma
Published in: British Journal of Haematology
Access to document
10.1111/j.1365-2141.2010.08111.x
Jan-Lukas Robertus, Joost Kluiver, Callista Weggemans, Geert Harms, Rogier M. Reijmers, Yolanthe Swart, Klaas Kok, Stefano Rosati, Ed Schuuring, Gustaaf van Imhoff, Steven T. Pals, Philip Kluin, Anke van den Berg
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma
Published in: Oncogene
Access to document
10.1038/sj.onc.1210147
BIC is a primary microRNA (pri-miR-155) that can be processed to mature miR-155. In this study, we show the crucial involvement of protein kinase C (PKC) and nuclear factor-kappa B (NF-kappa B) in the regulation of BIC expression upon B-cell receptor triggering. Surprisingly, Northern blot analysis did not reveal any miR-155 expression upon induction of BIC expression in the Burkitt lymphoma-derived Ramos cell line, whereas other microRNAs were clearly detectable. Ectopic expression of BIC in Ramos and HEK293 cells resulted in miR-155 expression in HEK293, but not in...
J. Kluiver, Anke van den Berg, Doetje de Jong, T. Blokzijl, G. Harms, E. Bouwman, Susan Jacobs, Sibrand Poppema, Bart-Jan Kroesen